Ayushman Bharat PM-JAY, launched on 23rd September 2018, has...
Category:
Health
Latest
Affordable, accessible healthcare road map for ‘healthy India’, says Jitendra Singh
“With increasing lifespan, changing lifestyles and environmental...
Sunak may ban cigarettes in UK for future generations -The Guardian
British Prime Minister Rishi Sunak Those measures include free vape...
Heart attack may be predicted in chest pain patients with new blood markers
If you have ever suffered chest pain, the possibility of a heart attack may have popped into your head. While chest pain is an important symptom of heart attacks, there are a variety of other conditions that can cause similar symptoms, and many of them are not serious. If a patient presents with chest pain at the hospital, doctors need to quickly determine if a heart attack is a culprit. Early treatment is important in limiting the damage that occurs.
It’s time people start wearing masks inside their homes as well: Union Health Ministry
Stressing on the need for vaccination and observing COVID-19 appropriate behaviours, the government advised that it is time people start wearing masks inside their homes as well.It also pitched for expediting the pace of the vaccination drive and asserted that women can take COVID-19 vaccine during menstruation as well.
Bengaluru, facing India’s second-highest COVID-19 surge, to enter lockdown
Microsoft, Amazon,Goldman Sachs are among the hundreds of multi-national firms with technology or IT operations in Bengaluru which employ thousands of English-speaking professionals.
Indian IT services giants including Infosys, Wipro and Tata Consultancy Services also have major operations in the city.
Govt asks Serum, Bharat Biotech to lower price of Covid vaccines: Report
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.
The Pune-based Serum Institute of India (SII), the world’s largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and Rs 600 per dose for private hospitals.
Both vaccines are available to the central government at a rate of Rs 150 per dose.
Europe embraces digital health pass,to face security, fraud, political challenges
The EU Commission plans to award a contract this month for a central system for verifying the digital passes, which will use QR codes that can be scanned into a smartphone app. It will also provide a template to help member countries develop their own apps – though some have already readied their own versions.
There is still no consensus on whether antibody tests provide sufficient proof that a person who has recovered from COVID-19 is immune, sources involved in the efforts say.
Member states also worry about the security of personal information, though the Commission has promised the online certificates will contain minimal data: name, date of birth, the specific health information, its date of issue and a unique identifier code.
How the EU’s digital health pass scheme would work
The pass, issued by a doctor or health centre, would feature a QR code containing pre-authenticated information that a traveller has been vaccinated against COVID-19 or has received a negative PCR test result.
The QR code, printed out on a piece of paper, would serve as proof of immunity. It would also be possible to scan the code into a smartphone app.
India’s new COVID-19 cases stay above 320,000, 2771 deaths, army called to help
“Please note that a huge fall in daily cases … is largely due to a heavy fall in testing. This should not be taken as an indication of falling cases, rather a matter of missing out on too many positive cases!” Rijo M John, a professor and health economist at the Indian Institute of Management in the southern state of Kerala, said in a post on Twitter.
Bharat Biotech seeks DCGI nod to extend shelf life of Covaxin: Report
The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius.
Covid surge likely due to lack of antibodies in seropositive people: CSIR
According to the paper, the aggregate sero-positivity of 10.14 per cent in its multi-centre study suggests India had a large pool of recovered immune subjects by September 2020, especially amongst its high contact workers and people using public transport, leading to a decline in new infections.
“However, the duration of such immunity may not be sufficient to prevent future outbreaks, even in highly affected regions, the paper said.
Union Health Secretary writes to states for systematic implementation of vaccination Phase III
The document also mentions that it is necessary for all CVCs to declare vaccine type, stock and prices for vaccination services being offered from May 1 onwards.In order for the public to make informed choices, vaccine types and prices will be displayed in the ‘appointments’ section.